Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907506804> ?p ?o ?g. }
Showing items 1 to 95 of
95
with 100 items per page.
- W2907506804 endingPage "81" @default.
- W2907506804 startingPage "75" @default.
- W2907506804 abstract "Nintedanib is a tyrosine kinase inhibitor approved for the treatment of idiopathic pulmonary fibrosis (IPF). The pathological pathways involved in fibrogenesis in IPF and interstitial lung disease associated with systemic sclerosis (SSc-ILD) show commonalities; both involve fibroblast activation, myofibroblast accumulation and deposition of extracellular matrix. The SENSCIS™ trial is a randomised, placebo-controlled Phase III trial that will evaluate the efficacy and safety of nintedanib in patients with SSc-ILD (NCT02597933).Approximately 520 patients with SSc (based on 2013 American College of Rheumatology/European League Against Rheumatism criteria) and ILD (≥10% fibrosis of the lungs, confirmed by central assessment of chest high resolution computed tomography), forced vital capacity (FVC) ≥40% predicted and diffusing capacity for carbon monoxide of 30-89% predicted will be enrolled. Patients will be randomised (1:1) to nintedanib 150 mg twice daily or placebo, stratified by the presence of anti-topoisomerase I antibody. To reflect real-world management, patients receiving prednisone (≤10 mg/day) and/or a stable dose of mycophenolate or methotrexate, will be eligible. The primary endpoint is the annual rate of decline in FVC (mL/ year) assessed over 52 weeks. Patients will remain on blinded study treatment until the last patient completes 52 weeks of treatment or for a maximum of 100 weeks of treatment. Key secondary endpoints are absolute changes from baseline in modified Rodnan skin score and St George's Respiratory Questionnaire at week 52.Recruitment for the trial began in November 2015.This trial will assess the efficacy and safety of nintedanib in patients with SSc-ILD." @default.
- W2907506804 created "2019-01-11" @default.
- W2907506804 creator A5007835079 @default.
- W2907506804 creator A5012966437 @default.
- W2907506804 creator A5013832706 @default.
- W2907506804 creator A5014703126 @default.
- W2907506804 creator A5018529897 @default.
- W2907506804 creator A5024950256 @default.
- W2907506804 creator A5025873566 @default.
- W2907506804 creator A5031932288 @default.
- W2907506804 creator A5037402194 @default.
- W2907506804 creator A5057747316 @default.
- W2907506804 creator A5068068331 @default.
- W2907506804 creator A5079069521 @default.
- W2907506804 creator A5080058829 @default.
- W2907506804 date "2017-07-01" @default.
- W2907506804 modified "2023-09-25" @default.
- W2907506804 title "Design of a randomised, placebo-controlled clinical trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease (SENSCIS™)." @default.
- W2907506804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28664834" @default.
- W2907506804 hasPublicationYear "2017" @default.
- W2907506804 type Work @default.
- W2907506804 sameAs 2907506804 @default.
- W2907506804 citedByCount "39" @default.
- W2907506804 countsByYear W29075068042018 @default.
- W2907506804 countsByYear W29075068042019 @default.
- W2907506804 countsByYear W29075068042020 @default.
- W2907506804 countsByYear W29075068042022 @default.
- W2907506804 countsByYear W29075068042023 @default.
- W2907506804 crossrefType "journal-article" @default.
- W2907506804 hasAuthorship W2907506804A5007835079 @default.
- W2907506804 hasAuthorship W2907506804A5012966437 @default.
- W2907506804 hasAuthorship W2907506804A5013832706 @default.
- W2907506804 hasAuthorship W2907506804A5014703126 @default.
- W2907506804 hasAuthorship W2907506804A5018529897 @default.
- W2907506804 hasAuthorship W2907506804A5024950256 @default.
- W2907506804 hasAuthorship W2907506804A5025873566 @default.
- W2907506804 hasAuthorship W2907506804A5031932288 @default.
- W2907506804 hasAuthorship W2907506804A5037402194 @default.
- W2907506804 hasAuthorship W2907506804A5057747316 @default.
- W2907506804 hasAuthorship W2907506804A5068068331 @default.
- W2907506804 hasAuthorship W2907506804A5079069521 @default.
- W2907506804 hasAuthorship W2907506804A5080058829 @default.
- W2907506804 hasConcept C126322002 @default.
- W2907506804 hasConcept C141071460 @default.
- W2907506804 hasConcept C142724271 @default.
- W2907506804 hasConcept C165637977 @default.
- W2907506804 hasConcept C203092338 @default.
- W2907506804 hasConcept C204787440 @default.
- W2907506804 hasConcept C27081682 @default.
- W2907506804 hasConcept C2777543607 @default.
- W2907506804 hasConcept C2777714996 @default.
- W2907506804 hasConcept C2778341716 @default.
- W2907506804 hasConcept C2780171596 @default.
- W2907506804 hasConcept C3018587741 @default.
- W2907506804 hasConcept C535046627 @default.
- W2907506804 hasConcept C55520419 @default.
- W2907506804 hasConcept C71924100 @default.
- W2907506804 hasConcept C90924648 @default.
- W2907506804 hasConceptScore W2907506804C126322002 @default.
- W2907506804 hasConceptScore W2907506804C141071460 @default.
- W2907506804 hasConceptScore W2907506804C142724271 @default.
- W2907506804 hasConceptScore W2907506804C165637977 @default.
- W2907506804 hasConceptScore W2907506804C203092338 @default.
- W2907506804 hasConceptScore W2907506804C204787440 @default.
- W2907506804 hasConceptScore W2907506804C27081682 @default.
- W2907506804 hasConceptScore W2907506804C2777543607 @default.
- W2907506804 hasConceptScore W2907506804C2777714996 @default.
- W2907506804 hasConceptScore W2907506804C2778341716 @default.
- W2907506804 hasConceptScore W2907506804C2780171596 @default.
- W2907506804 hasConceptScore W2907506804C3018587741 @default.
- W2907506804 hasConceptScore W2907506804C535046627 @default.
- W2907506804 hasConceptScore W2907506804C55520419 @default.
- W2907506804 hasConceptScore W2907506804C71924100 @default.
- W2907506804 hasConceptScore W2907506804C90924648 @default.
- W2907506804 hasIssue "4" @default.
- W2907506804 hasLocation W29075068041 @default.
- W2907506804 hasOpenAccess W2907506804 @default.
- W2907506804 hasPrimaryLocation W29075068041 @default.
- W2907506804 hasRelatedWork W2051083934 @default.
- W2907506804 hasRelatedWork W2747720470 @default.
- W2907506804 hasRelatedWork W2907506804 @default.
- W2907506804 hasRelatedWork W2956839011 @default.
- W2907506804 hasRelatedWork W2990809657 @default.
- W2907506804 hasRelatedWork W3010166382 @default.
- W2907506804 hasRelatedWork W3088035281 @default.
- W2907506804 hasRelatedWork W3139014258 @default.
- W2907506804 hasRelatedWork W3194524700 @default.
- W2907506804 hasRelatedWork W4291743724 @default.
- W2907506804 hasVolume "35 Suppl 106" @default.
- W2907506804 isParatext "false" @default.
- W2907506804 isRetracted "false" @default.
- W2907506804 magId "2907506804" @default.
- W2907506804 workType "article" @default.